EVA
MONTE SERRANO
Investigadora Predoctoral
Hospital Universitario de Salamanca
Salamanca, EspañaHospital Universitario de Salamanca -ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2024
-
Loss of VRK1 alters the nuclear phosphoproteome in the DNA damage response to doxorubicin
Chemico-Biological Interactions, Vol. 391
-
Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathy
Journal of Molecular Medicine, Vol. 102, Núm. 6, pp. 801-817
-
VRK1 Regulates Sensitivity to Oxidative Stress by Altering Histone Epigenetic Modifications and the Nuclear Phosphoproteome in Tumor Cells
International Journal of Molecular Sciences, Vol. 25, Núm. 9
2023
-
The pattern of histone H3 epigenetic posttranslational modifications is regulated by the VRK1 chromatin kinase
Epigenetics and Chromatin, Vol. 16, Núm. 1
-
VRK1 Kinase Activity Modulating Histone H4K16 Acetylation Inhibited by SIRT2 and VRK-IN-1
International Journal of Molecular Sciences, Vol. 24, Núm. 5
2022
-
The VRK1 chromatin kinase regulates the acetyltransferase activity of Tip60/KAT5 by sequential phosphorylations in response to DNA damage
Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1865, Núm. 8